<SEC-DOCUMENT>0001096906-13-001542.txt : 20140115
<SEC-HEADER>0001096906-13-001542.hdr.sgml : 20140115
<ACCEPTANCE-DATETIME>20131001131523
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001096906-13-001542
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20131001

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UTAH MEDICAL PRODUCTS INC
		CENTRAL INDEX KEY:			0000706698
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				870342734
		STATE OF INCORPORATION:			UT
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		7043 S 300 WEST
		CITY:			MIDVALE
		STATE:			UT
		ZIP:			84047
		BUSINESS PHONE:		8015661200
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<html>
<head>
    <title>utmedcorr.htm</title>
    <!--Licensed to: Southridge-->
    <!--Document Created using EDGARizerAgent 5.4.4.0-->
    <!--Copyright 1995 - 2013 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
<hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
</div>

<div>&#160;</div>

<div style="TEXT-ALIGN: center"><img src="utmdlogo.jpg" alt=""><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">October 1, 2013</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Martin James, Senior Assistant Chief Accountant</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Division of Corporation Finance</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">U.S. Securities and Exchange Commission</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Washington, D.C. 20549-0306</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">VIA FACSIMILE [703-813-6985] and U.S. Certified Mail</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Re:</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Utah Medical Products, Inc.&#160;&#160;(UTMD)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Form 10-K for the fiscal year ended December 31, 2012</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Filed March 7, 2013</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>File No. 1--12575</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Dear Mr. James:</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Thank you for your review of Utah Medical Products, Inc.&#8217;s (UTMD&#8217;s) September 13, 2013 response to the SEC comment letter dated August 30, 2013. This is UTMD&#8217;s response to your letter dated September 19, 2013, and which will also be filed on EDGAR as private correspondence with the SEC.&#160;&#160;For ease of reference, I have incorporated the SEC comments in italics followed by UTMD&#8217;s responses.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Form 10-K for the Fiscal Year Ended December 31, 2012</font></font></div>
</div>

<div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Item 8. Financial Statements and Supplementary Data</font></font></div>
</div>

<div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Report of Independent Registered Public Accounting Firm, page 30</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">1.</font></div>
</td>
<td>
<div align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We note your response to prior comment 1 and your statement that Simkins Jones LLC &#8220;satisfied itself regarding the reasonableness of those intangibles in 2012&#8221;. Please have your auditors explain to us how the audit of management&#8217;s assessment of intangible asset impairment was performed. Explain to us whether realizability of the intangible assets is based on just the results of Femcare or on the consolidated results of Utah Medical. Clarify for us which audit firm performed the audit work or the different stages of the audit work..</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Jones Simkins LLC response to Comment 1.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Femcare Group Limited (Femcare) intangibles (the intangibles) were a result of a business combination in March 2011.&#160;&#160;The Norton Practice audited Femcare, including management&#8217;s assessment of impairment (please see UTMD response to question #2 in the September 16, 2013 response).&#160;&#160;As part of its 2011 audit, Jones Simkins LLC performed audit procedures related to the business combination and the resulting intangibles.&#160;&#160;Therefore, Jones Simkins understands the valuation metrics with which these assets are recorded on the financial statements of Femcare. While performing its 2012 audit work related to the consolidation, Jones Simkins' analysis of the intangibles included review of The Norton Practice audit opinion.&#160; Applying its previous knowledge about the intangibles to arrive at an expectation of the current carrying amount, Jones Simkins did not identify any events or changes in circumstances which would indicate that the carrying amount of the intangibles may not be recoverable.&#160;&#160;Jones Simkins' previous comment regarding the &#8220;reasonableness of those intangibles&#8221; related to these events.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">The realizability of the Femcare intangibles are based on the results of Femcare.<br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-SIZE: 10pt">1</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2.</font></div>
</td>
<td>
<div align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We note that you did not provide all of the acknowledgements previously requested. Please provide, in writing, a statement from the company acknowledging that:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="TEXT-ALIGN: right; WIDTH: 45pt">
<div style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;&#160; </font></font></font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;the company is responsible for the adequacy and accuracy of the disclosure in the filing;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="TEXT-ALIGN: right; WIDTH: 45pt">
<div style="TEXT-ALIGN: right"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;staff comments or changes to disclosure in response to staff comments do not foreclose the Commission from taking any action with respect to the filing; and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="TEXT-ALIGN: right; WIDTH: 45pt">
<div style="TEXT-ALIGN: right"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">UTMD Response to Comment 2.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Respectfully, UTMD has previously answered this.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Thank you for your review of the referenced disclosures.&#160;&#160;I hope that the above responses are complete and to the satisfaction of the SEC.&#160;&#160;If not, please give us the opportunity to augment the responses as needed.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Sincerely,</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">/s/ Paul O. Richins</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Paul O. Richins</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Principal Financial Officer</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Direct tele no. (801) 569-4200</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Fax no. (801) 566-7305</font></div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div>
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-SIZE: 10pt">2</font></div>
</div>

<div>
<hr style="COLOR: black" noshade size="2">
 &#160;</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>utmdlogo.jpg
<TEXT>
begin 644 utmdlogo.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``(!`0(!`0("`@("`@("`P4#`P,#
M`P8$!`,%!P8'!P<&!P<("0L)"`@*"`<'"@T*"@L,#`P,!PD.#PT,#@L,#`S_
MVP!#`0("`@,#`P8#`P8,"`<(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`S_P``1"`!_`'8#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#]_*X3XJ_M
M1_#/X$ZO;:?XW^(O@7P;?WD/VBWMM<U^UTZ:>+<5WHDTBEER",@8R#7=U\^Z
M;\5/$4W_``53UGP2VK7)\)VWPIL-<CTS:GDI?2:O>PO/G&[<8HT7KC"CC/-`
M&]_P\4_9]_Z+K\'/_"TTW_X]1_P\4_9]_P"BZ_!S_P`+33?_`(]7R3_P49^(
MGQ`TS]ES]I_Q_H'Q2\>^%-:^$?BQ-.\/PZ-=V\-JD,MAH,A2:-X7\S:]S<,N
M3P96]L7OVZ_VO]9_X)[^(O!6EZ)X]\2^(=%^&=_:>+_B(==C;5-0U;0[VX>Q
M>V6:*(*GV:%KK4"&VG%A$,XDH`^J/^'BG[/O_1=?@Y_X6FF__'J/^'BG[/O_
M`$77X.?^%IIO_P`>KQ;P3^V]XC\,?\%`/V@_"MUH'Q'^(/AG0X_#EQH,7AS2
MH;VSTA9],\V9-^]#NF<[P"6&.<@<5WW_``2V^.'B+]H7]F_7?$GB>;6WOS\0
M/%MA!!K%NEO?:=:6VO7L%M:31IPCPPQQQE<DC9RQ/-`'5_\`#Q3]GW_HNOP<
M_P#"TTW_`./4?\/%/V??^BZ_!S_PM--_^/5XK\'O^"AM]X*_:/\`CCH?Q/N$
MM_"=I/J?B'X?WD:`O>:?I#0Z=JVGJ`!ON(;U4E5,EW744`^X0/F;_AM3XN?%
MGXS?#3PEXT\0?$?0KJ;QS\1='\3:1\.8XY;]18#3[C3;=6\IF:.W@O$5G'WR
M=Q)!%`'Z!_\`#Q3]GW_HNOP<_P#"TTW_`./4?\/%/V??^BZ_!S_PM--_^/5\
M\?L_>'?%O[1G[8GQ^\*:A\6OC#HFC?#6'PI9:!%:ZA;6MU;"ZT*&XGDN4:W9
M)+AYB7?S%*[BP"@<5\[>.?\`@JU\:/AEX1DO)M;M=:\3>&-'\;>"O/?3XX-*
MUS6;'QMH7AZPUV6%!PJ1W[R21QLL9?SE`4%=H!^B'_#Q3]GW_HNOP<_\+33?
M_CU'_#Q3]GW_`*+K\'/_``M--_\`CU1^&_@9_P`,^!?&VO\`Q<^).KV_AS3+
MFY\0'6=2ADTW4D6$M)<26XA"6^S:746WE*,8(8<5\(R?\%,_B++^R/\`MB0Z
MAXL>T\>:'X*N?BIX`NHK)K6XT/2;RU<)I^R6,;YM.NH#'(Y4AC<Q'O@`'Z4?
M"?\`:`\!_'JVO9O`WC;PCXTATUD2[DT+6+?45M6<$J)#"[!20IP#C.#Z5UU4
M/"MU)?>%]-FE8O+-:Q.['JS%`2:OT`%%%%`!7QW^VWXI\%^&?VN]$U#3-6^*
M_A_XP:!X(N[^>Z\$Z#%J_P!I\-F[021W<$\4L<RI<H&C"+YZLS[.'=6^Q*^.
M?CI^R]KWQQ_X*H"[DN_'GAGP5=?!J?1;W6]`9;1+J9]91VL3=-&YC<Q9?]TR
M2@#(84`>6>./CA^S'\6?V,/B1X"E\2_$;5OAOXDU/3KKQI\1K33VD0WFK1V.
MI6]Y<7'E;8T>*XLE++`(H$*QD1K'A?;;3XE_#:YU+X[^&M-\/_$#XOV>LZO=
M6_Q"N]-TI+^SM)WLH;632$(,;3F"T2)6@MUF=-Q#_O&*U\H:W^PWXD^"7QG^
M+^LZ+X!\8:W\#?"/Q`\-K<?"VPM9!8^+_#]KX<T6VBO+",*)+R?3[JV$AMS(
MT5RMM+$R-*$KZ/\`V"M?U+]B/X(^+_`7C?PG\0+[6])\7^)-?T[4-+\-7FIK
MXRM-1U.ZU.WGCDAC9$N"ET(9(KAHW22)L_)M<@'-?L7_`!!^!_[*GB"'2/A9
MJWQ1^,NJ^-/A]X>U[[;96J:I]HT33XI=)L)V=4A43$6[QR(?WA>,EE4Y%>B?
ML7?M*?`_P2VA>`?`NN>)+K4OB9XN\7:D+#5K":*^TO6([IM2U>RO$:*-K1X7
MO1LCE4$HR%2X(=OFG_@GQ\&_&O[#?[7,>O?$;P/XQLX?%?PXO;^9/#WA^^U^
MQT/4=2\7ZOJ[:.);*&1`]O#>1ACPA8L5)4@U9\,_`CXA?#G]N+0OVG=?\`^*
M[3PKXF^(^O7UYH.GV+ZEK7A[2KKPYIVD6-_<65N'DW2RZ:9)HXA))$MS#N&4
ME"@'MOQS\$?LZ_"6]\-:%\0)-8UKQ%\,?',/C_P_');27.I:CKNO7VK2VUM;
M)"@-TSRB[Q`H(1;:*20@1[QYQX]^$G@GP+\8?$?Q<&B?M2>!?%6B>(-2\7S3
MV'AVPO8+,:GI-G:7CQ[H;BWD@\G1XBR[FECD=B<"1!4GQ_\``_C'Q[^WAX(_
M:6T3P'XTU;P'\-=:L-.N-);29H-9U6T?2]:M+C5;?3Y52X=;675H,(4$LB)=
M-&C83?\`5'Q2^)T/Q]_9V^*6F>&M#\8RS_\`"*WL-N;_`,.WNF_;YIK6=4A@
M2YCCDE<$`':I`+J,Y)``/E+X?_$SP-K7B36?'O@7Q+^TXGB?XZ^'[#Q!=6.G
M>&]-_M/Q'I>G:;:VZZS;QSVG[E&BGM@?+*,TUPHCB!^5?1?CS^Q?^SI\"?V8
MO^$M\7:5X@L_A=X6^'NI^$KW1V$\KSV&L7]E>7-Q.I!NVOVNX(I3-O$@D>1S
M\^&'F7B3X&11?L-_LYVU[I/QX\`?''P!\(;.+PYXE\%:%=7%UIE\NG6:3Z+>
MQK')"XDGAA+VUZBQ'R"1)&R%AZ__`,%`?`GQ+^+?_!&SQ!H>L:%+K7Q9U7PC
MI:ZQI>A6YN/.U3?:M=I;HF=R"02D;<_*M`#OA%X&\+?M@:)XT^'_`/POKXA^
M/=.^&>N#PIXFT.^2PM;M9;::.1H+]TM$FN(YXX]GFY"RQO+RSY9>'_:X7X)_
M\%&M6T&*P_X6KXFU^X^'>H17]EX'M88[J/PUXCM0@BU%KI1%$93;1SV\3.)?
M,MMX1DW9:/V._B!H,/B?XR?#+3?[$^-OA/QSXGEM=.U(&RL_B+H$VK3W`TF[
M<C[D@8RVERP/D2L&'[N256YO_@D_X<\2?L,R>(H?B'X"\=:=:?%71/#'BC3]
M3M/#MYJDFGSP:!8Z==:)?):Q226]Q;2VA*;T$<BSG8VY64`'VE^R[I]XWPRL
M]5N/$?CS6X-8@BEMK7Q9I-KI=_I**NWR6@AMH&1LCYA(&.1P<5Z17$?!OXXP
M_&:?6TA\,>-_#G]B301%O$.B2Z:M]YUO'<![?S/]8JB0(Y'W)$=&`92*[>@`
MHHHH`*\U^-G[(O@#]HC7+34O%VD7VHWEC!]FA>#6;ZR"Q[BV"L$R*3DGD@GW
MKTJB@#P'_AV%\%/^A8U?_P`*K5__`)*KRG]L?X0_LC_L!_!B]\=_%1[GPOH,
M&4B$GBS6'N=2FP2(+>%;HO-*?[J@X&22%!(]0_X*8_\`!2/P#_P2Y_9@U/XD
M>.IFN&4_9-$T6WD5;S7[YE)2WBST'!9W((1%9L$X4_R`?\%$/^"C7Q-_X*;?
MM!7OQ`^)6KM<RDM%I.DV[,NG:!:DY6WMHR3M7@;F.7<C<Q)H`_435O\`@X__
M`&1[;5+F.P_9E^*5S9+*RP33?$2]ADECS\K,@N&"DC!*AFQTR>M5E_X.0_V4
M5.1^R]\2P?4?$J^_^.U^)=%`']CG_!/_`.`?P'_;\_8^\$?&#3OA[XC\.V7C
M>UENXM.N_&.JSS6H2XEAPSK<@')B)X'0BO.O^"O\GP%_X)+_`++=C\4-4^%'
MB7QQ!?>(;;0/L%MXZU6R>-IH;B42EVG<8'D$8Q_$/2O2_P#@W(_Y0H?`+_L#
M77_IPNJ^<O\`@\P_Y1,:%_V473/_`$CU"@#X/'_!R;^S,,_\8I>/.>O_`!=;
M4>?UK=^&'_!QE^R+XA\>Z99>*?V;OB1X9T&ZF$=YJEK\1-1U&2Q0\>9Y'FQE
MP#C(#9QG`8X4_A[10!_:1^SU^R?^RU^UA\)M+\<_#G/B_P`*:PFZUU#3_%^K
MNA(^\C@W0:.1>C1N`ZG@@&NW7_@F)\%5/'AG6!]/%>K_`/R57\EG_!*#_@KK
M\3?^"3?QSB\0^$+R75/".IS1CQ+X4N)B+'7(1P2.OE7"@G9,HRIX(9"R-_7W
M^Q9^V5X$_;Y_9P\._%#X=:H-2\.^(8=VQ\+<Z=.O$MK<("=DT;?*PR0>&4LK
M*Q`-OX(?LV^#OV<[+4+?PAIMWIT6J.DER)]4N[[>4!"X-Q+(5^\?NXSGFNZH
MHH`****`"J^JZK;:%I=S?7MQ#:6=G$T]Q/,X2.&-069V8\!0`22>@%6*_-S_
M`(.HOVT[C]DC_@E+XATC2;QK3Q%\6[V/P?:M&V)([65'EO7'^R;>)X2>QN%H
M`_GX_P""['_!5#5/^"J'[;VL>(;:ZN!\./"<DNC^"K!LJL=DKX:[9>TMRRB1
MLC(7RT)(C!KXMHKT_P#8Q_92\2?MP_M2^"/A1X20?VYXVU..PCF9"\=E%RTU
MS(!SY<,2R2MCG;&<<T`>845]$?\`!6']G#PU^R#_`,%#_BC\,O!\5U'X<\$Z
ME'I=E]IF,LTH2VAW2.W=G<LYP``6(```%?.]`']D7_!N1_RA0^`7_8&NO_3A
M=5\Y?\'F'_*)C0O^RBZ9_P"D>H5]&_\`!N1_RA0^`7_8&NO_`$X75?.7_!YA
M_P`HF-"_[*+IG_I'J%`'\M5%%?67_!&C]@S2O^"E'[6VI?";4;AK"]UKPAK%
MSHM\)&5+#4X(/,M99`/OQ>8`'7NC-C!P0`?)M?IG_P`&Q'_!6"Y_X)_?MK6?
M@3Q-J31_"KXO7<.E:DDTA\G2-28[+2_7/"C<1%*>!Y;AFSY2BOSE^(OP^UCX
M3?$#7/"WB&QFTO7_``W?SZ7J5G,,26MS#(T<L;>ZNK#\*QPVTY'!'0T`?W]T
M5\H_\$1/VRYOV\/^"8/PI\?:A<FZ\0G2_P"QM=D8Y>2_LF-M-(WO+Y8F^DPK
MZNH`****`"OYV?\`@]_^+4FH?&KX#^!%F81:3HFI:]+$#PS74\4",1Z@6D@'
M^\:_HFK^87_@]8CD'_!47X?L0_E'X66`4D?*6&K:OG'ORN?J*`/Q]K]N_P#@
MR<_9FM?&/[3GQ;^*][;+*_@?0[70M-=QGRI[^1WDD7T98K0IG^[.P[U^(E?T
M>?\`!D*;7_AESXX[,?;O^$JL?.'_`$S^R'R_U\R@#\B/^#@3_E,Q^T'_`-C.
MW_HB*OCJOLO_`(.$].FTO_@L_P#M`QW$9C=O$:S`'NCVL#H?Q5@?QKXTH`_L
MB_X-R/\`E"A\`O\`L#77_IPNJ^<O^#S#_E$QH7_91=,_](]0KV3_`(-@?C+X
M>^*W_!&3X56&BZC!=ZAX-6]T36;97!EL+I;V>4(X[;HI8I%]5D'O7S;_`,'I
MWQN\/>'_`-@#P#\/YM0M_P#A*O$GC2#5[6P#CSOL=K:7233E>H027$*9/4OQ
MT.`#^9BOTV_X-'/^4SGAC_L6]9_])J_,FOT__P"#0[29]2_X+):+-$FZ.P\*
MZQ/.?[B&)(P?^^I%'XT`7/\`@[O_`&6K3X!_\%6)?%.F6Z6]A\6/#UKXAE$:
M[4%[&SVEQ@>K>1%(Q[M,3WK\M*_=#_@^#GMV^/'P!C4I]K70-6:0#[VPW%N$
MS[9#X_&OPOH`_I3_`.#)?XLR>(/V*OBYX+DE,G_",>,8M4C0G_5)>V:)@>VZ
MS<_4FOVIK\!/^#&1)!;_`+4#$/Y1;PJ%)'REA_;.<>_*Y^HK]^Z`"BBB@`K^
M>C_@^!^#DMK\0?@)\0(H28;[3M4\/7,P'W&AD@N(5/U$\Y'^Z:_H7KX!_P"#
MEW]B"?\`;;_X)2^-(=(M&O/%/PXD3QII$:1[I)OLJ.+F)<<DM:R7&%'WG5!0
M!_(#7[6?\&5?[55I\/?VN/B9\)=0NEA_X6/H<&JZ6KG_`%UWIS2%XE_VFM[F
M5_I;GTK\4Z[G]FC]HCQ/^R7\?_"/Q*\&WGV'Q-X+U.'5+"5@2C.AYCD&1NC=
M=R.O\2NP[T`?K%_P>6_L,:A\+?VRO#?QUT^S=O#7Q/TZ+2M3N$3Y;?5K./8J
MN>@\VT6(IGD_9YO[M?C)7]D_PK^)/P,_X.-_^"8ES!>0+=Z!XJMEM-;TQ95_
MM/P?J\:AOE8CY)HG(>.3;MD1E)!1V6OYG_\`@JS_`,$2/C'_`,$J/B'=IXDT
MFY\1_#R><C2/&>FVS-I]W&3\B3XS]FGQUCD/)SL9U^:@#Y__`&;_`-K_`.*7
M['WB6ZU?X7>/_%?@/4+Z,17<FBZC):B[09PLJJ=L@!)(#`X)XK&^-WQ\\;?M
M*_$"Y\5_$'Q9X@\9^)+M5CEU+6;Z2\N&1<[4#N20@R<*,`9X%<C10`5_01_P
M93?L0W^DV?Q-_:#U>R>"TU2%?!OAR21,?:461+B^E7/50\=K&&'!9)5ZJ:_/
M/_@CI_P;_?%?_@J3XXTS6K[3]2\#_!J&=7U/Q5>6YB:_B!RT.G(X_?RL,KY@
M!BCY+$D"-OZ`/^"G_P"WM\,?^#?[_@G#I?ACP-9Z7IWB*'2VT'X=>&$(D9YE
M7!O)E/S-%$S>;+(W,DC!2VZ7-`'X:_\`!V+^UE:_M*_\%:-;T/2[E;G2OA/I
M%MX2#QD%&NU:2XN_^!)+<&%O>`^E?F;5[Q/XFU#QKXEU#6=6O+C4=5U:YDO;
MV[G<O+=32,7DD=CR69F))[DU!IFFW&M:E;V=I!-=7=W*L,$,2%Y)G8@*JJ.2
M22``.N:`/Z7/^#*?X-R^%/V"?B7XUGA,3>,/&?V*!B/]=!96D6&'MYMS,OU4
MU^S-?.W_``2=_8U7]@/_`()X_"WX621QIJOA_1DFUDH<A]2N&:XN\-_$!/+(
MJG^ZJU]$T`%%%%`!39(UFC9'4,K##*1D$>AIU%`'\A/_``<4_P#!).]_X)C_
M`+:-_?\`A_39$^$7Q'N)M5\+3QI^YTYR=T^FD_PF%F^0'K"T9R2'Q^?-?W.?
MMU_L/^`O^"B'[-&O_"[XB:=]LT36DWP7,6!=:3=J#Y-W;N0=DL9)P>C`LK!E
M9E/\A/\`P52_X)(_%'_@D_\`&V3PYXVL7U'PQJ,KGP[XJM(6&GZ[".>#SY4Z
M@C?"QW*>1N0J[`'._P#!-O\`X*2_%3_@F1^T%:^-?A?J1\V[*6NJZ'<AI=/\
M0P;LB">($$G).QU(="3M(R0?[0OA)JVI_&O]GWPY?^/?!T'AS5O$VBV]QKGA
MB\E2_3399HE:6TD8J%EV%BA^4`X/%?S'_P#!J3_P2['[:7[;'_"T_%&G^?\`
M#WX+S0Z@%F3,6IZR?FLX.>&6+:;A\="D*L,25_5-0!\5_&7_`(-W?V,OCIK,
MVHZQ\"?#-A>7#^8[Z%<W>B(23D_NK26*/G_=K3^`W_!`K]C_`/9OUJWU+PW\
M"O"$VHVI#17&M&?6VC8=&47DDJJP]0`:^P:*`/"_^"C'[0_B[]C/]AGQ_P#$
M3X=>![7QSKW@?23?6VAM<&VA$$>/-E(1262"+?*8UVEUB*JRD@U_&1^V'^V3
M\1/V\?COJWQ&^)_B&X\0^)=5(0,PV06,"DE+:WB'RQ0IDX5>Y).69F/]T]U:
MQWUM)#-&DT,RE)(W4,KJ1@@@\$$=J_CH_P"#@#_@F)+_`,$P_P!OW7-$TFR>
M'X<^-=_B#P?*`?+BM9'/FV>?[UM(3'C)/EF%C]^@#X>K]>O^#3S_`())W7[5
MO[44/QY\8Z6W_"N/A1>++I`N(_W>MZZN&B"Y^\EKE9F/_/3R!R"X'S-_P1?_
M`."('Q"_X*U?%Z"1(+[PQ\)-&N0/$7BMX<+@8+6EGN&);EA@=UB#!G_A1_ZY
MOV=/V>?"'[*'P2\.?#OP%HUOH'A+PK9K9:?90_P*,EG9CR\CL6=W;+,S,Q))
M-`':T444`%%%%`!1110`5Q?[07[.G@;]JSX4ZGX'^(OA?2?%_A36%VW6G:C#
MYD;$?==3PR2*>5="&4\@@UVE%`'C7["/[!OPY_X)Q_`&'X;?##3;G3O#D6H7
M6IN;N?[1=7,]Q(69I)<`OM01Q*3R(X8P22"3[+110`4444`%>`_M\?\`!,OX
M0?\`!2_PYX2TGXN>'IM=L?!FL#6+!8+I[21F*%)('D3#^1(-N]%92QCC.1M%
M>_44`8/PQ^%_ASX*^`-*\*^$=#TOPUX;T.`6NGZ9IMLMO:V<0Z*B*`!U)/J2
12>36]110`4444`%%%%`'_]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
